Systematic review of randomized trials for unresectable hepatocellular carcinoma chemoembolization improves survival
July 9th, 2007 by admin
Author's objectives
To assess the impact on survival of primary medical treatments for people with unresectable hepatocellular cancer.
Author's conclusions
Chemoembolisation improves survival in people with unresectable HCC; tamoxifen offers no survival benefits for people with advanced disease.
Structured abstract from Database of Abstracts of Reviews of Effects
Posted in Gastroenterology & Liver Diseases |